BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  CARsgen® Announces 2024 Interim Results

  August 29, 2024

   · 

  7 min read
• Press Releases

  BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results

  Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance Management Expects Third Quarter 2024 Revenues of at Least $6.5 Million, with a Gross Profit Margin of 52%+

  August 29, 2024

   · 

  10 min read
• FDA

  BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family

  August 29, 2024

   · 

  4 min read
• Business

  EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

  August 29, 2024

   · 

  1 min read
• Business

  Erasca to Present at Upcoming Investor Conferences in September

  August 29, 2024

   · 

  1 min read
• Press Releases

  QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in chronic diseases

  August 29, 2024

   · 

  5 min read
• Press Releases

  Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

  August 29, 2024

   · 

  1 min read
• Business

  Nanalysis Announces Second Quarter 2024 Results

  August 29, 2024

   · 

  12 min read
• Press Releases

  iTeos to Participate in Upcoming September 2024 Investor Conferences

  August 29, 2024

   · 

  1 min read
• Press Releases

  Akeso’s 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization

  August 29, 2024

   · 

  9 min read